Experiment 383353

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationVARTERASIAN,ML: MOHAMMAD,RM: EILENDR,DS: HULBURD,K: RODRIGUEZ,DH: PEMBERTON,PA: PLUDA,JM: DAN,MD: PETTIT,GR: CHEN,BDM: AL-KATIB,AM:. (1998). PHASE I STUDY OF BRYOSTATIN 1 IN PATIENTS WITH RELAPSED NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA.. 16(1)
Amount utilized
Compound isolated
DiseaseWHEN ADMINISTERED IN A CONTINUOUS DIFFUSION OVER 72 HOURS, COMPOUND INDUCED MYALGIA IN 2/3 PATIENTS.
Dose amount180.0 MCG
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE